Clinical Use of Clozapine Serum Level and Management of Adverse Effects in an Adolescent with Difficult to Treat Schizophrenia

Bostwick JR , Guthrie SK , Ellingrod VL : Antipsychotic-induced hyperprolactinemia. Pharmacotherapy, 29:64–73, 2009.

Breier A , Liffick E , Hummer TA , Vohs JL , Yang Z , Mehdiyoun NF , Visco AC , Metzler E , Zhng Y , Francis MM : Effects of 12-month, double-blind N-acetyl cysteine on symptoms, cognition and brain morphology in early phase schizophrenia spectrum disorders. Schizophr Res, 199:395–402, 2018.

Cooper TB : Clozapine plasma level monitoring: Current status. Psychiatr Q, 67:297–311, 1996.

Couchman L , Bowskill SV , Handley S , Patel MX , Flanagan RJ : Plasma clozapine and norclozapine in relation to prescribed dose and other factors in patients aged <18 years: Data from a therapeutic drug monitoring service, 1994–2010. Early Interv Psychiatry, 7:122–130, 2013.

Ellison JC , Dufresne RL : A review of the clinical utility of serum clozapine and norclozapine levels. Mental Health Clinician, 5:68–73, 2015.

Ermakov EA , Dmitrieva EM , Parshukova DA , Kazantseva DV , Vasilieva AR , Smirnova LP : Oxidative stress-related mechanisms in schizophrenia pathogenesis and new treatment perspectives. Oxid Med Cell Longev, 2021:1–37, 2021.

Faulkner G , Cohn TA : Pharmacologic and nonpharmacologic strategies for weight gain and metabolic disturbance in patients treated with antipsychotic medications. Can J Psychiatry, 51:502–511, 2006.

Freudenreich O , McEvoy J : Guidelines for prescribing clozapine in schizophrenia. Edited by Friedman M and Marder S, UpToDate, 2021. Available at https://www.uptodate.com/contents/guidelines-for-prescribing-clozapine-in-schizophrenia Accessed December 10, 2021 .

Gaftanyuk O , Trestman RL : Scolpolamine patch for clozapine-induced sialorrhea. Psychiatr Serv, 55:318, 2004.

Goh KK. Clozapine/sertraline interaction. React Wkly 1463:16, 2013.

Klauser P , Xin L , Fournier M , Griffa A , Cleusix M , Jenni R , Cuenod M , Gruetter R , Hagmann P , Conus P , Baumann PS : N-acetylcysteine add-on treatment leads to an improvement of fornix white matter integrity in early psychosis: A double-blind randomized placebo-controlled trial. Transl Psychiatry, 8:1–8, 2018.

Leadbetter R , Shutty MS , Pavalonis D , Vieweg V , Higgins P , Downs M : Clozapine-induced weight gain: Prevalence and clinical relevance. Am J Psychiatry, 149: 68–72, 1992.

Nielsen J , Correll CU , Manu P , Kane JM : Termination of clozapine treatment due to medical reasons: When is it warranted and how can it be avoided?. J Clin Psychiatry, 74:603–613, 2013.

Paribello P , Manchia M , Zedda M , Pinna F , Carpiniello B : Leukocytosis associated with clozapine treatment: A case series and systematic review of the literature. Medicina, 57:816, 2021.

Popli AR , Fuller MA , Jaskiw GE : Sertraline and psychotic symptoms: A case series. Ann Clin Psychiatry, 9:15–17, 1997.

Reed VA , Buitelaar JK , Anand E , Day KA , Treuer T , Upadhyaya HP , Coghill DR , Kryzhanovskaya LA , Savill NC : The safety of atomoxetine for the treatment of children and adolescents with attention-deficit/hyperactivity disorder: A comprehensive review of over a decade of research. CNS Drugs, 30:603–628, 2016.

Schoretsanitis G , Kane JM , Ruan CJ , Spina E , Hiemke C , de Leon J : A comprehensive review of the clinical utility of and a combined analysis of the clozapine/norclozapine ratio in therapeutic drug monitoring for adult patients. Expert Rev Clin Pharmacol, 12:603–621, 2019.

Sepehrmanesh Z , Heidary M , Akasheh N , Akbari H , Heidary M : Therapeutic effect of adjunctive N-acetyl cysteine (NAC) on symptoms of chronic schizophrenia: A double-blind, randomized clinical trial. Prog Neuropsychopharmacol Biol Psychiatry, 82:289–296, 2018.

Solmi M , Fornaro M , Toyoshima K , Carvalho AF , Köhler CA , Veronese N , Stubbs B , de Bartolomeis A , Correll CU : Systematic review and exploratory meta-analysis of the efficacy, safety, and biological effects of psychostimulants and atomoxetine in patients with schizophrenia or schizoaffective disorder. CNS Spectrums, 24:479–495, 2019.

Stroup TS , Gray N : Management of common adverse effects of antipsychotic medications. World Psychiatry, 17:341–356, 2018.

Sweet MG , Schmidt-Dalton TA , Weiss PM , Madsen KP : Evaluation and management of abnormal uterine bleeding in premenopausal women. Am Fam Physician, 85:35–43, 2012.

Thangavelu K , Geetanjali S : Menstrual disturbance and galactorrhea in people taking conventional antipsychotic medications. Exp Clin Psychopharmacol, 14:459, 2006.

Ulrich S , Baumann B , Wolf R , Lehmann D , Peters B , Bogerts B , Meyer FP : Therapeutic drug monitoring of clozapine and relapse–a retrospective study of routine. Int J Clin Pharmacol Ther, 41:3–13, 2003.

Varma S , Bishara D , Besag FM , Taylor D : Clozapine-related EEG changes and seizures: Dose and plasma-level relationships. Ther Adv Psychopharmacol, 1:47–66, 2011.

Wang M , Tong JH , Zhu G , Liang GM , Yan HF , Wang XZ : Metformin for treatment of antipsychotic-induced weight gain: A randomized, placebo-controlled study. Schizophr Res, 138:54–57, 2012.

Warnez S , Alessi-Severini S : Clozapine: A review of clinical practice guidelines and prescribing trends. BMC Psychiatry, 14:1–5, 2014.

Whitney Z , Procyshyn RM , Fredrikson DH , Barr AM : Treatment of clozapine-associated weight gain: A systematic review. Eur J Clin Pharmacol, 71:389–401, 2015.

Willborn RJ , Hall CP , Fuller MA : Recycling N-acetylcysteine: A review of evidence for adjunctive therapy in schizophrenia. Mental Health Clinician, 9:116–123, 2019.

Wohkittel C , Gerlach M , Taurines R , Wewetzer C , Unterecker S , Burger R , Schreck D , Mehler-Wex C , Romanos M , Egberts K : Relationship between clozapine dose, serum concentration, and clinical outcome in children and adolescents in clinical practice. J Neural Transm, 123:1021–1031, 2016.

Yeşilyurt S , Aras İ, Altınbaş K , Atagün Mİ , Kurt E : Pathophysiology of clozapine induced sialorrhea and current treatment choices. Dusunen Adam J Psychiatry Neurol Sci, 23:275, 2010.

Young CR , Bowers Jr MB , Mazure CM : Management of the adverse effects of clozapine. Schizophr Bull, 24:381–390, 1998.